m6A mRNA methylation: Biological features, mechanisms, and therapeutic potentials in type 2 diabetes mellitus

被引:11
作者
Ren, Yuanyuan [1 ]
Li, Zi [1 ]
Li, Jiaoyu [1 ]
Liang, Rui [1 ]
Wang, Zhen [1 ]
Bai, Yiduo [1 ]
Yang, Yafang [1 ]
Tang, Qian [1 ]
Fu, Yaolei [1 ]
Zhang, Xiaobo [1 ]
Zhang, Yu [1 ]
Yu, Yi [1 ,2 ]
Xiong, Yuyan [1 ,2 ,3 ]
机构
[1] Northwest Univ, Coll Life Sci, Fac Life Sci & Med, Key Lab Resource Biol & Biotechnol Western China,M, Xian, Shaanxi, Peoples R China
[2] Northwest Univ, Sch Med, Xian, Shaanxi, Peoples R China
[3] Northwest Univ, Coll Life Sci, Fac Life Sci & Med, Xian, Shaanxi, Peoples R China
关键词
m(6)A methylation; mechanisms; therapeutic potentials; type 2 diabetes mellitus; BETA-CELL DEDIFFERENTIATION; INSULIN-RESISTANCE; GENE-EXPRESSION; NUCLEAR-RNA; N-6-METHYLADENOSINE RNA; OXIDATIVE STRESS; M6A MODIFICATION; STRUCTURAL BASIS; SKELETAL-MUSCLE; FTO EXPRESSION;
D O I
10.1111/obr.13639
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
As the most common internal post-transcriptional RNA modification in eukaryotic cells, N6-methyladenosine (m(6)A) performs a dynamic and reversible role in a variety of biological processes mediated by methyltransferases (writers), demethylases (erasers), and m(6)A binding proteins (readers). M(6)A methylation enables transcriptome conversion in different signals that regulate various physiological activities and organ development. Over the past few years, emerging studies have identified that mRNA m(6)A regulators defect in beta-cell leads to abnormal regulation of the target mRNAs, thereby resulting in beta-cell dysfunction and loss of beta-cell identity and mass, which are strongly associated with type 2 diabetes mellitus (T2DM) pathogenesis. Also, mRNA m(6)A modification has been implicated with insulin resistance in muscles, fat, and liver cells/tissues. In this review, we elaborate on the biological features of m(6)A methylation; provide a comprehensive overview of the underlying mechanisms that how it controls beta-cell function, identity, and mass as well as insulin resistance; highlight its connections to glucose metabolism and lipid metabolism linking to T2DM; and further discuss its role in diabetes complications and its therapeutic potentials for T2DM diagnosis and treatment.
引用
收藏
页数:18
相关论文
共 168 条
[1]   Hepatic ALKBH5 Regulation of Glucose and Lipid Metabolism [J].
Aamodt, Kristie ;
Polay, Madison ;
Gonzales, Valeria R. Salerno ;
Kulkarni, Rohit .
DIABETES, 2023, 72
[2]   Roles of mTOR in the Regulation of Pancreatic β-Cell Mass and Insulin Secretion [J].
Asahara, Shun-ichiro ;
Inoue, Hiroyuki ;
Watanabe, Hitoshi ;
Kido, Yoshiaki .
BIOMOLECULES, 2022, 12 (05)
[3]   Dynamic regulation of N6,2′-O-dimethyladenosine (m6Am) in obesity [J].
Ben-Haim, Moshe Shay ;
Pinto, Yishay ;
Moshitch-Moshkovitz, Sharon ;
Hershkovitz, Vera ;
Kol, Nitzan ;
Diamant-Levi, Tammy ;
Beeri, Michal Schnaider ;
Amariglio, Ninette ;
Cohen, Haim Y. ;
Rechavi, Gideon .
NATURE COMMUNICATIONS, 2021, 12 (01)
[4]   The SMAD2/3 interactome reveals that TGFβ controls m6A mRNA methylation in pluripotency [J].
Bertero, Alessandro ;
Brown, Stephanie ;
Madrigal, Pedro ;
Osnato, Anna ;
Ortmann, Daniel ;
Yiangou, Loukia ;
Kadiwala, Juned ;
Hubner, Nina C. ;
de los Mozos, Igor Ruiz ;
Sadee, Christoph ;
Lenaerts, An-Sofie ;
Nakanoh, Shota ;
Grandy, Rodrigo ;
Farnell, Edward ;
Ule, Jernej ;
Stunnenberg, Hendrik G. ;
Mendjan, Sasha ;
Vallier, Ludovic .
NATURE, 2018, 555 (7695) :256-+
[5]   Functional beta-cell maturation is marked by an increased glucose threshold and by expression of urocortin 3 [J].
Blum, Barak ;
Hrvatin, Sinisa ;
Schuetz, Christian ;
Bonal, Claire ;
Rezania, Alireza ;
Melton, Douglas A. .
NATURE BIOTECHNOLOGY, 2012, 30 (03) :261-264
[6]   Obesity and diabetes [J].
Boutari, Chrysoula ;
DeMarsilis, Antea ;
Mantzoros, Christos S. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 202
[7]   FTO contributes to hepatic metabolism regulation through regulation of leptin action and STAT3 signalling in liver [J].
Bravard, Amelie ;
Vial, Guillaume ;
Chauvin, Marie-Agnes ;
Rouille, Yves ;
Bailleul, Bernard ;
Vidal, Hubert ;
Rieusset, Jennifer .
CELL COMMUNICATION AND SIGNALING, 2014, 12
[8]   FTO Is Increased in Muscle During Type 2 Diabetes, and Its Overexpression in Myotubes Alters Insulin Signaling, Enhances Lipogenesis and ROS Production, and Induces Mitochondrial Dysfunction [J].
Bravard, Amelie ;
Lefai, Etienne ;
Meugnier, Emmanuelle ;
Pesenti, Sandra ;
Disse, Emmanuel ;
Vouillarmet, Julien ;
Peretti, Noel ;
Rabasa-Lhoret, Remi ;
Laville, Martine ;
Vidal, Hubert ;
Rieusset, Jennifer .
DIABETES, 2011, 60 (01) :258-268
[9]   FTO mediates cell-autonomous effects on adipogenesis and adipocyte lipid content by regulating gene expression via 6mA DNA modifications [J].
Carli, Jayne F. Martin ;
LeDuc, Charles A. ;
Zhang, Yiying ;
Stratigopoulos, George ;
Leibel, Rudolph L. .
JOURNAL OF LIPID RESEARCH, 2018, 59 (08) :1446-1460
[10]   FTO promotes SREBP1c maturation and enhances CIDEC transcription during lipid accumulation in HepG2 cells [J].
Chen, Ao ;
Chen, Xiaodong ;
Cheng, Shiqiang ;
Shu, Le ;
Yan, Meiping ;
Yao, Lun ;
Wang, Binyu ;
Huang, Shuguang ;
Zhou, Lei ;
Yang, Zaiqing ;
Liu, Guoquan .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2018, 1863 (05) :538-548